Rentschler Biopharma SE, a global contract development and manufacturing organization (CDMO) for biopharmaceuticals, is expanding its services in Japan and South Korea. With their well-established and growing biopharma industries, Japan and South Korea are key markets for biopharmaceutical development. Rentschler Biopharma has been active in the region for many years, serving a wide range of clients, with support from its established regional partner, Summit Pharmaceuticals International (SPI...